September 2026
The global multiple sclerosis therapeutics market size was evaluated at USD 37.16 billion in 2026 and is predicted to hit around USD 66.80 billion by 2035, growing at a CAGR of 6.90%.
September 2026
The multiple sclerosis diagnostics market size was USD 6.20 billion in 2026, with leading multiple sclerosis diagnostics market players including F. Hoffmann-La Roche Ltd., Siemens Healthineers, GE HealthCare, Thermo Fisher Scientific.
June 2026
The U.S. multiple sclerosis drugs market size is estimated to hit around USD 18.43 billion by 2035 increasing from USD 8.44 billion in 2025, with a CAGR of 8.12%.
April 2026
The global multiple sclerosis drugs market size is estimated to hit around USD 49.13 billion by 2035, increasing from USD 22.96 billion in 2025, with a CAGR of 7.90%.
September 2026
The global melanoma therapeutics market size accounted for USD 8.16 billion in 2026 and is expected to hit around USD 19.61 billion by 2035, at a CAGR of 10.25%.
September 2026
The global targeted therapeutics market size was estimated at USD 91.76 billion in 2026 and is projected to hit around USD 163.91 billion by 2035 with a CAGR of 6.69%.
September 2026
The global non-Hodgkin's lymphoma therapeutics market size is estimated to hit around USD 20.94 billion by 2034, increasing from USD 11.80 billion in 2026, with a CAGR of 7.43%.
September 2026
The anti-inflammatory therapeutics market size was estimated at USD 113.58 billion in 2026 and is expected to hit USD 164.44 billion by 2035, with a CAGR of 4.14%.
September 2026
The global narcolepsy therapeutics market size is accounted at USD 4.46 billion in 2026 and is expected to hit around USD 9.31 billion by 2035 with a CAGR of 8.49%.
September 2026
The global multiplex assays market size was estimated at USD 2.30 billion in 2026 and is expected to hit around USD 7.51 billion by 2035, growing at a CAGR of 14.15%.
September 2026
The global women's health therapeutics market size is predicted to hit around USD 66.62 billion by 2034 from USD 48.57 billion in 2026, with a CAGR of 4.03%.
September 2026
The global fallopian tube cancer therapeutics market size is expected to increase from USD 2.14 billion in 2026 to hit around USD 5.41 billion by 2035, growing at a CAGR of 10.86%.
September 2026
The global plasma therapeutics market size is estimated to hit around USD 52.26 billion by 2035 increasing from USD 28.35 billion in 2025, with a CAGR of 6.31%.
September 2026
The global multiplex biomarker imaging market size is projected to hit around USD 1,780.14 million by 2035 from USD 659.01 million in 2026 with a CAGR of 11.70%.
September 2026
The global plasma protein therapeutics market size is projected to cross around USD 48.43 billion by 2034 from USD 32.66 billion in 2026 with a CAGR of 5.06%.
September 2026
The global colorectal cancer therapeutics market size is expected to hit around USD 19.95 billion by 2034 from USD 12.79 billion in 2024 with a CAGR of 4.55%.
September 2026
The global atherosclerosis drugs market size is projected to hit around USD 25.07 billion by 2035, increasing from USD 18.24 billion in 2026, with a CAGR of 3.60%.
September 2026
The sepsis therapeutics market size was valued at USD 4,27 billion in 2026 and is expected to Attain around USD 7.36 billion by 2034 with a CAGR of 7.06%.
September 2026
The global digital therapeutics market size was exhibited at USD 11.98 billion in 2026 and is projected to surpass around USD 65.31 billion by 2035, with a remarkable CAGR of 20.97%.
September 2026
The pain management therapeutics market size accounted for USD 91.54 billion in 2026 and is predicted to hit around USD 127.78 billion by 2035, with a CAGR of 3.78%.
September 2026
The global breast cancer therapeutics market size was valued at USD 35.91 billion in 2026 and is expected to hit around USD 66.72 billion by 2035, at a CAGR of 7.27%.
September 2026
The tau protein targeting therapeutics market size reached USD 1,314.50 million in 2026, with leading tau protein targeting therapeutics market companies including Biogen Inc., F. Hoffmann-La Roche Ltd., Eli Lilly and Company, AbbVie Inc.
September 2026
The amyloid beta therapeutics market size was USD 6.12 billion in 2026, with leading amyloid beta therapeutics market players including Biogen Inc., Eisai Co., Ltd., F. Hoffmann-La Roche Ltd., Eli Lilly and Company, Novartis AG.
September 2026
The global Duchenne muscular dystrophy therapeutics market size was evaluated at USD 7.80 billion in 2026 and is predicted to hit around USD 26.88 billion by 2035, growing at a CAGR of 14.80%.
September 2026
The US peptide therapeutics market size stood at USD 22.63 billion in 2026, with major US peptide therapeutics market companies including AbbVie, GlaxoSmithKline plc., Amgen, Inc.
September 2026
The brain health supplements and therapeutics market size was USD 20.42 billion in 2026, with leading brain health supplements and therapeutics market players including Neuriva, Prevagen, Danone, Nestlé Health Science.
September 2026
The lung cancer therapeutics market size totalled USD 38.23 billion in 2026, with major lung cancer therapeutics market players including AstraZeneca, BoehringerIngelheim, Bristol-Myers Squibb Company, Eli Lilly and Company, Hoffmann-La Roche, Merck & Co, Pfizer Inc.
September 2026
The cancer therapeutics and biotherapeutics market size reached USD 228.73 billion in 2026, with leading cancer therapeutics and biotherapeutics market companies including Amgen Inc., Bristol-Myers Squibb, Celgene Corporation.
August 2026
The pruritus therapeutics market size stood at USD 12.26 billion in 2026, with major pruritus therapeutics market companies including Bristol-Myers Squibb, Novartis AGÂ , Pfizer Inc.,Teva Pharmaceuticals.
August 2026
The global cancer therapeutics market size was evaluated at USD 212.58 billion in 2025 and is expected to surpass around USD 501.07 billion by 2034 with a CAGR of 8.95%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com